Patricia Donahue, MBA

Patricia Donahue, MBA
Pharmaceutical and Biotechnology Global Business Development

Patricia Donahue has 20 years of global business development experience in pharmaceutical, biotechnology and drug delivery industries leading corporate transactions and collaborations on the buy and sell side under a variety of deal structures with emerging and established commercial entities. Her experience spans from small molecule and antibody product development, marketing and sales, strategic planning, and program, alliance and operations management. This breadth and depth of experience provides unique insights to create innovative deal structures, value and differentiate products and technologies, improve communications across all functions and levels, and focus limited resources to deliver exceptional outcomes. As a global business development leader at XOMA, Ms. Donahue increased value through fully- funded antibody discovery and development collaborations which delivered over $56M in realized revenue and had the potential for $500M in additional milestone and royalty payments. As a member of the global business development teams within multi-national pharmaceutical companies, she led global scouting for products or technologies, created and implemented standard procedures for approval and execution of deals, facilitated M&A asset evaluation, managed US, Europe and Asia collaborations to exceed pipeline and revenue expectations, and managed cross-functional, cross-national teams to bring two products through clinical development to launch. Ms. Donahue holds a B.A. in biology and chemistry from Gustavus Adolphus College and a MBA in management from the University of St. Thomas.

"Cori Gorman has an extraordinarily high level of expertise, which was one of the critical factors in choosing her for this. When things come up again, she is the person I will go to."

- Senior scientist at a biotechnology company.

An independent third party conducted a quality survey for DNA Bridges,Inc. The third party, in association with Dunn and Bradstreet, interviewed several clients. All clients stated that the costs met expectations and projects were competed on time.